Systemic Delivery of mPEG‐Masked Trispecific T‐Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Delivery of mPEG‐Masked Trispecific T‐Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect
Authors
Keywords
-
Journal
Advanced Science
Volume -, Issue -, Pages 2203523
Publisher
Wiley
Online
2022-09-12
DOI
10.1002/advs.202203523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy
- (2022) Yingchao Hao et al. JOURNAL OF NANOBIOTECHNOLOGY
- Strategies of engineering nanomedicines for tumor retention
- (2022) Xindi Qian et al. JOURNAL OF CONTROLLED RELEASE
- Turning cold tumors hot: from molecular mechanisms to clinical applications
- (2022) Jiahui Zhang et al. TRENDS IN IMMUNOLOGY
- Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response
- (2021) Michelle von Locquenghien et al. JOURNAL OF CLINICAL INVESTIGATION
- CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance
- (2021) Cheng Wang et al. Cell Stem Cell
- PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer
- (2021) Chunhua Chen et al. JCI Insight
- Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy
- (2021) DaeYong Lee et al. ADVANCED MATERIALS
- The state of the art of bispecific antibodies for treating human malignancies
- (2021) Shuhang Wang et al. EMBO Molecular Medicine
- Cancer stem cells in TNBC
- (2021) Zhan Hua et al. SEMINARS IN CANCER BIOLOGY
- Progress and challenges of immunotherapy in triple-negative breast cancer
- (2021) Yinxing Zhu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape
- (2021) Giulia Salvadori et al. Cell Metabolism
- Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
- (2021) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance
- (2021) Xuezhi Cao et al. Nature Communications
- Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
- (2021) Shaojun Peng et al. Advanced Science
- PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
- (2020) Fatmah A. Mansour et al. OncoImmunology
- Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics
- (2020) Heliang Li et al. Cellular & Molecular Immunology
- Role of Immunotherapy in Triple-Negative Breast Cancer
- (2020) Tanya E. Keenan et al. Journal of the National Comprehensive Cancer Network
- T cell-engaging therapies — BiTEs and beyond
- (2020) Maria-Elisabeth Goebeler et al. Nature Reviews Clinical Oncology
- NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
- (2020) Ge Qin et al. Nature Communications
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
- (2020) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel
- (2020) Feihu Wang et al. Nature Biomedical Engineering
- T Cell-Engaging Therapy for Solid Tumors
- (2020) Maria de Miguel et al. CLINICAL CANCER RESEARCH
- cGAS-STING pathway in cancer biotherapy
- (2020) Yang Wang et al. Molecular Cancer
- Engineering Prodrug Nanomedicine for Cancer Immunotherapy
- (2020) Bin Yang et al. Advanced Science
- Enhancing anti-tumour efficacy with immunotherapy combinations
- (2020) Funda Meric-Bernstam et al. LANCET
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
- (2020) Muyue Yang et al. Bioactive Materials
- Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
- (2019) Anping Li et al. Journal of Hematology & Oncology
- Cancer stemness, intratumoral heterogeneity, and immune response across cancers
- (2019) Alex Miranda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
- (2019) Park et al. Cancers
- Cancer stem cells and their unique role in metastatic spread
- (2019) Teresa Bernadette Steinbichler et al. SEMINARS IN CANCER BIOLOGY
- CD44 promotes PD-L1 expression and its tumor-intrinsic function in breast and lung cancers
- (2019) Tim Kong et al. CANCER RESEARCH
- Hyaluronan-CD44 axis orchestrates cancer stem cell functions
- (2019) Spyros S. Skandalis et al. CELLULAR SIGNALLING
- STING: a master regulator in the cancer-immunity cycle
- (2019) Yuanyuan Zhu et al. Molecular Cancer
- Intratumor Performance and Therapeutic Efficacy of PAMAM Dendrimers Carried by Clustered Nanoparticles
- (2019) Hong-Jun Li et al. NANO LETTERS
- Harnessing innate immunity in cancer therapy
- (2019) Olivier Demaria et al. NATURE
- Bispecific antibody based therapeutics: Strengths and challenges
- (2018) Archana Thakur et al. BLOOD REVIEWS
- Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
- (2018) Minan Wang et al. FASEB JOURNAL
- STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
- (2018) Jung-Mao Hsu et al. Nature Communications
- Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
- (2018) Peixin Dong et al. Frontiers in Oncology
- Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
- (2017) Mary R. Doherty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cytotoxic T lymphocyte immune synapse at a glance
- (2016) Nele M. G. Dieckmann et al. JOURNAL OF CELL SCIENCE
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Biophysical Aspects of T Lymphocyte Activation at the Immune Synapse
- (2016) Claire Hivroz et al. Frontiers in Immunology
- Multifunctional Tumor pH-Sensitive Self-Assembled Nanoparticles for Bimodal Imaging and Treatment of Resistant Heterogeneous Tumors
- (2014) Daishun Ling et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The immune synapse clears and excludes molecules above a size threshold
- (2014) Adam N. R. Cartwright et al. Nature Communications
- The Immunological Synapse
- (2014) M. L. Dustin Cancer Immunology Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started